Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy

Abstract Whether patients with advanced hepatocellular carcinoma (aHCC) benefit from hepatitis C virus (HCV) eradication is uncertain. We aimed to investigate whether a survival benefit was conferred by HCV eradication in aHCC patients. This retrospective cohort study enrolled 168 HCV‐infected aHCC...

Full description

Bibliographic Details
Main Authors: Ming‐Lun Yeh, Hsing‐Tao Kuo, Ching‐I Huang, Chung‐Feng Huang, Ming‐Yen Hsieh, Po‐Cheng Liang, I‐Hung Lin, Meng‐Hsuan Hsieh, Zu‐Yau Lin, Shinn‐Chern Chen, Chia‐Yen Dai, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
direct acting antivirals
hepatitis C virus
hepatocellular carcinoma
Sorafenib
survival
Online Access:https://doi.org/10.1002/kjm2.12303

Internet

https://doi.org/10.1002/kjm2.12303

Similar Items